In 2023, the standardized mortality rates for endocrine, nutritional, and metabolic diseases show significant variation across countries. South Africa, with the highest value of 166.6 deaths per 100,000 people, experienced a marginal increase. Croatia saw a substantial rise of 14.17%, whereas Brazil and Costa Rica also showed notable increases. Several countries, including Argentina and Denmark, experienced slight declines. Japan registered the lowest rate at 9.8 but decreased by nearly 1%. Over the past five years, compound annual growth trends indicate varied developments in mortality rates globally.
Future trends to monitor include:
- The impact of healthcare advancements and policies on reducing mortality rates in high-burden countries like South Africa and Croatia.
- Potential shifts due to global health initiatives focusing on nutrition and metabolic disorders.
- The influence of aging populations in countries with traditionally low rates, such as Japan and Finland, which might affect mortality trends in the future.
Top countries in Endocrine, Nutritional and Metabolic Diseases Mortality by Country
| # | 10 Countries | Units (Deaths) Per Hundred Thousand Persons, Standardised Rates | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 South Africa | 166.6 | 2023 | +0.24% | +0.41% | View data |
| 2 | 2 Croatia | 125 | 2023 | +8.23% | +14.17% | View data |
| 3 | 3 Brazil | 86 | 2023 | +0.82% | +4.35% | View data |
| 4 | 4 Costa Rica | 73.3 | 2023 | 0% | +10.5% | View data |
| 5 | 5 Peru | 60.9 | 2023 | 0% | +4.62% | View data |
| 6 | 6 Colombia | 60.5 | 2023 | 0% | +9.01% | View data |
| 7 | 7 United States | 59.2 | 2023 | +4.59% | +7% | View data |
| 8 | 8 Czech Republic | 54.7 | 2023 | +2.63% | +3.53% | View data |
| 9 | 9 Israel | 48.9 | 2023 | +0.62% | +0.41% | View data |
| 10 | 10 Austria | 45.6 | 2023 | +3.64% | +3.82% | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...
